1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


Table 2: 

Sensitivity, specificity, positive predictive value, and negative predictive value for 3T MRA and 1.5T MRA (DSA as the criterion standard): adequate occlusion/aneurysm remnant


SE (95% CI)Sp (95% CI)PPV (95% CI)NPV (95% CI)
3T MRA0.74 (0.60–0.89)0.93 (0.88–0.99)0.81 (0.68–0.95)0.90 (0.84–0.96)
1.5T MRA0.54 (0.38–0.71)0.98 (0.95–1.00)0.90 (0.78–1.00)0.85 (0.78–0.92)
  • 

    Note:—Sp = specificity.